Abstract
Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Y H Ling, A K el-Naggar, W Priebe and R Perez-Soler
Molecular Pharmacology May 1996, 49 (5) 832-841;